Carcinoma in situ, other and unspecified urinary organs

DOID MESH PheWeb

CD2_INSITU_URINARY_NOS

No definition available.

Endpoint definition

↥

FinnGen phenotype data

321302 individuals

Apply sex-specific rule None

321302

Check conditions None

321302

Filter registries

Hospital Discharge: ICD-10 D09.1&

Hospital discharge: ICD-9 2339

Hospital discharge: ICD-8 $!$

Cause of death: ICD-10 D09.1&

Cause of death: ICD-9 2339

Cause of death: ICD-8 $!$

205

Check pre-conditions, main-only, mode, ICD version

Look only at ICD versions H.D: 10, 8, 9 ; C.O.D: 10, 8, 9

Check minimum number of events None

Include endpoints None

CD2_INSITU_URINARY_NOS

Extra metadata

Level in the ICD hierarchy 3

First used in FinnGen datafreeze DF2

Parent code in ICD-10 D09

Name in latin Carcinoma in situ organorum urinariorum aliorum sive non specificatorum

Similar endpoints

↥

List of similar endpoints to Carcinoma in situ, other and unspecified urinary organs based on the number of shared cases.

Broader endpoints:

Narrower endpoints:

None

Show all endpoint correlations

Summary Statistics

↥

Key figures

	All	Female	Male
Number of individuals	12	7	5
Unadjusted prevalence (%)	0.00	0.00	0.00
Mean age at first event (years)	56.12	48.90	66.23

Mortality

Follow-up	Absolute risk	HR [95% CI]	p	N
1998–2019	-	-	-	-
15 years	-	-	-	-
5 years	-	-	-	-
1 year	-	-	-	-

Age distribution of first events

Year distribution of first events

Cumulative Incidence

Correlations

↥

Index endpoint: CD2_INSITU_URINARY_NOS – Carcinoma in situ, other and unspecified urinary organs
GWS hits:

Survival analyses between endpoints

↥

Plot

before Carcinoma in situ, other and unspecified urinary organs
after Carcinoma in situ, other and unspecified urinary organs

Loading survival analyses plot

Table

Loading survival analyses table

Drugs most likely to be purchased after Carcinoma in situ, other and unspecified urinary organs

↥